Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sanofi MS drug nears green light after pass-the-parcel marathon
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
Determination and characterization of a cannabinoid receptor in rat brain.
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
GEMSP: A New Therapeutic Approach to Multiple Sclerosis.
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multipl
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Neuroprotective effect of masitinib in rats with postischemic stroke.
UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a review.
Remyelination therapy goes to trial for multiple sclerosis
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
8th FENS Forum of Neuroscience
First patient treated in Mapi Pharma's Phase IIa clinical trial of GA Depot for relapsing remitting multiple sclerosis (RRMS)
Tip variant focal segmental glomerulosclerosis associated with interferon-β treatment of multiple sclerosis.
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Vitamin D intake and incidence of multiple sclerosis.
Laquinimod in multiple sclerosis.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Prospective memory, emotional valence, and multiple sclerosis.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.

Pages